148 related articles for article (PubMed ID: 7184466)
1. Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid.
Lauharanta J; Juvakoski T; Kanerva L; Lassus A
Arch Dermatol Res; 1982; 273(1-2):111-4. PubMed ID: 7184466
[TBL] [Abstract][Full Text] [Related]
2. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.
Herfst MJ; De Wolff FA
Eur J Clin Pharmacol; 1982; 23(1):75-80. PubMed ID: 7128674
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of 8-MOP in serum and in suction blister fluid.
Reymond JL; Beani JC; Racinet H; Bonnot D; Beriel H; Amblard P
Photodermatol; 1988 Feb; 5(1):51-2. PubMed ID: 3353318
[No Abstract] [Full Text] [Related]
4. Intraindividual and interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patients.
Herfst MJ; De Wolff FA
Clin Pharmacol Ther; 1983 Jul; 34(1):117-24. PubMed ID: 6861433
[TBL] [Abstract][Full Text] [Related]
5. [PUVA therapy: decrease of the 8-methoxypsoralen level following local administration].
Meffert H; Metz D
Dermatol Monatsschr; 1980 Aug; 166(8):566-7. PubMed ID: 7461250
[No Abstract] [Full Text] [Related]
6. Plasma levels of 8-methoxypsoralen following oral or bath-water treatment.
Thomas SE; O'Sullivan J; Balac N
Br J Dermatol; 1991 Jul; 125(1):56-8. PubMed ID: 1873204
[TBL] [Abstract][Full Text] [Related]
7. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
Aubin F; Makki S; Humbert P; Muret P; Agache P
Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
[TBL] [Abstract][Full Text] [Related]
8. [8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].
Nitsche V; Raff M; Bardach H
Arch Dermatol Res; 1981; 271(1):11-7. PubMed ID: 7294879
[TBL] [Abstract][Full Text] [Related]
9. Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.
Siddiqui AH; Stolk L; Korthals Altes-Levij van Vinninghe HR; Kammeijer A; Cormane RH
Arch Dermatol Res; 1982; 273(3-4):219-23. PubMed ID: 7165351
[TBL] [Abstract][Full Text] [Related]
10. Determination of 8-methoxypsoralen in suction-blister fluid and serum by liquid chromatography.
Herfst MJ; Edelbroek PM; de Wolff FA
Clin Chem; 1980 Dec; 26(13):1825-8. PubMed ID: 7438426
[TBL] [Abstract][Full Text] [Related]
11. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration.
Humbert P; Treffel P; Makki S; Millet J; Agache P
Arch Dermatol Res; 1991; 283(5):297-9. PubMed ID: 1929553
[TBL] [Abstract][Full Text] [Related]
12. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
[TBL] [Abstract][Full Text] [Related]
13. [Psoriasis phototherapy. Antipsoriatic efficacy of 8-methoxypsoralen and tar baths].
Rowe E; Meffert H; Miehe M; Sönnichsen N
Dermatol Monatsschr; 1985; 171(3):180-4. PubMed ID: 3996697
[No Abstract] [Full Text] [Related]
14. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
Nørgaard M; Hueg B; Staberg B
Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679
[TBL] [Abstract][Full Text] [Related]
15. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
Yang XY; Gasparro FP; DeLeo VA; Santella RM
J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen.
Stolk LM; Siddiqui AH; Westerhof W; Cormane RH
Br J Dermatol; 1985 Apr; 112(4):469-73. PubMed ID: 3994922
[TBL] [Abstract][Full Text] [Related]
17. Difference in bioavailability between two brands of 8-methoxypsoralen and its impact on the clinical response in psoriatic patients.
Herfst MJ; De Wolff FA
Br J Clin Pharmacol; 1982 Apr; 13(4):519-22. PubMed ID: 7066167
[TBL] [Abstract][Full Text] [Related]
18. Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method.
Korting HC; Schäfer-Korting M; Roser-Maass E; Mutschler E
Arch Dermatol Res; 1982; 272(1-2):9-20. PubMed ID: 7165325
[TBL] [Abstract][Full Text] [Related]
19. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
Tanew A; Ortel B; Rappersberger K; Hönigsmann H
J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089
[TBL] [Abstract][Full Text] [Related]
20. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
